Sort
16,179 grants matching “malaria”
Host Immune Responses to Antigens of Malaria Parasites
$662,429Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya
$661,687Megan Song McHenry · Indiana University Indianapolis · R01 · FY2024 · HD
Lead optimization and target identification of drugs targeting hypnozoites
$661,635Dennis E Kyle · University Of Georgia · R01 · FY2022 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome.
$661,630Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2023 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome.
$661,630Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2025 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome.
$661,630Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2024 · AI
The role of γδ T cells in fetal and infant immune defense against malaria
$661,396Margaret E Feeney · University Of California, San Francisco · R01 · FY2022 · AI
Development of vector-specific, resistance-breaking insecticides to reduce malari
$661,190Paul R Carlier · Virginia Polytechnic Inst And St Univ · R01 · FY2012 · AI
COVID Transmission and Morbidity in Malawi (COVID-TMM)
$661,062Clarissa Valim · Boston University Medical Campus · R01 · FY2022 · AI
Safety and efficacy of PfSPZ malaria vaccine in malaria-exposed adults
$661,033Christopher V. Plowe · University Of Maryland Baltimore · U01 · FY2015 · AI
Development of endochin-like quinolones for babesiosis therapy
$660,513Choukri Ben Mamoun · Yale University · R01 · FY2019 · AI
MBRS SCORE Program at UPR, Medical Sciences Campus
$660,444University Of Puerto Rico Med Sciences · S06 · FY2001 · GM
Host and parasite factors influencing P. vivax RBC invasion and asexual development
$660,178David Serre · University Of Maryland Baltimore · R01 · FY2022 · AI
Peptide-Protein Conjugate Vaccines
$659,916Rachel Schneerson · Child Health And Human Development · Z01 · FY2007 · HD
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
$659,915Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2023 · MD
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
$659,894Michael L Gross · Washington University · R24 · FY2022 · GM
Epidemiology Project
$659,874Moses Robert Kamya · University Of California, San Francisco · U19 · FY2018 · AI
Vaccine-Induced Immunity to CMV
$659,845Don J Diamond · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
Great Ape Reservoirs of Human Malaria
$659,718Beatrice H Hahn · University Of Pennsylvania · R01 · FY2017 · AI
Clinical Studies of Interactions Between HIV and Malaria
$659,659University Of California San Francisco · U01 · FY2004 · AI
Second-Generation Novel Liver Stage Active Antimalarials
$659,657Jane X Kelly · Portland State University · R01 · FY2023 · AI
Second-Generation Novel Liver Stage Active Antimalarials
$659,657Jane X Kelly · Portland State University · R01 · FY2025 · AI
Second-Generation Novel Liver Stage Active Antimalarials
$659,657Jane X Kelly · Portland State University · R01 · FY2024 · AI
Second-Generation Novel Liver Stage Active Antimalarials
$659,657Jane X Kelly · Portland State University · R01 · FY2022 · AI
Defining the targets of broad intervention antimalarial agents
$659,642Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2014 · AI